Drugs / Betulinic Acid

Trials 2

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00701987 Jun 2008 → Jun 2009 melanoma Advanced Life Sciences, Inc. Unknown No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT00346502 Jan 2006 → Dec 2015 melanocytic nevus University of Illinois at Chicago Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Betulinic Acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT00346502 ↗
Known as .beta.-betulinic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Known as ALS-357 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00701987 ↗
Known as Betulic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Known as BETULINIC ACID GLUTARYL HEMI ESTER ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Known as Lupatic acid ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Known as Mairin ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Known as NSC-113090 ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Known as NSC-677578 ChEMBL registry synonym — accepted as the source's own label CHEMBL269277 ↗
Modality Small molecule — CHEMBL269277 ↗
Route Topical “Topical Application of 20% Betulinic Acid Ointment” NCT00346502 ↗